rs371783831
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_024589.3(ROGDI):c.301G>A(p.Ala101Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000748 in 1,564,100 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A101G) has been classified as Uncertain significance.
Frequency
Consequence
NM_024589.3 missense
Scores
Clinical Significance
Conservation
Publications
- amelocerebrohypohidrotic syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, ClinGen, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ROGDI | NM_024589.3 | c.301G>A | p.Ala101Thr | missense_variant | Exon 5 of 11 | ENST00000322048.12 | NP_078865.1 | |
| ROGDI | XM_006720947.5 | c.301G>A | p.Ala101Thr | missense_variant | Exon 5 of 11 | XP_006721010.1 | ||
| ROGDI | XM_047434636.1 | c.31G>A | p.Ala11Thr | missense_variant | Exon 3 of 9 | XP_047290592.1 | ||
| ROGDI | NR_046480.2 | n.308G>A | non_coding_transcript_exon_variant | Exon 4 of 10 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ROGDI | ENST00000322048.12 | c.301G>A | p.Ala101Thr | missense_variant | Exon 5 of 11 | 1 | NM_024589.3 | ENSP00000322832.6 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152164Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000400 AC: 7AN: 174908 AF XY: 0.0000431 show subpopulations
GnomAD4 exome AF: 0.0000751 AC: 106AN: 1411936Hom.: 0 Cov.: 31 AF XY: 0.0000602 AC XY: 42AN XY: 697550 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000723 AC: 11AN: 152164Hom.: 0 Cov.: 33 AF XY: 0.0000673 AC XY: 5AN XY: 74308 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1
ROGDI: PM2 -
Amelocerebrohypohidrotic syndrome Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 101 of the ROGDI protein (p.Ala101Thr). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with ROGDI-related conditions. ClinVar contains an entry for this variant (Variation ID: 575566). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The threonine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at